Location
301 Route 17 North, Suite 800, Rutherford, NJ
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John A. Ballantyne Revocable Living Trust dated 08/01/2017:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Glucotrack, Inc. 10%+ Owner Common Stock, par value $0.001 per share 2.74M $85.1M $31.00 Mar 12, 2025 Direct
Glucotrack, Inc. 10%+ Owner Series A Common Warrant 132K Nov 14, 2024 Direct
Glucotrack, Inc. 10%+ Owner Warrants to Purchase Common Stock 59.3K Jul 30, 2024 Direct
Glucotrack, Inc. 10%+ Owner Series B Common Warrant 0 Mar 12, 2025 Direct

Insider Reports Filed by John A. Ballantyne Revocable Living Trust dated 08/01/2017

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GCTK Glucotrack, Inc. Jul 30, 2024 8 $4.09M 4 Mar 31, 2025 10%+ Owner
GCTK Glucotrack, Inc. Jul 30, 2024 0 $0 3 Mar 28, 2025 10%+ Owner